GlaxoSmithKline Trading Services Limited
IE-MF-000008351 · Ireland · Dublin 24
GlaxoSmithKline Trading Services Limited is registered in the European database on medical devices as a manufacturer, with 12 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIa | 12 |
|---|
Among these devices, 9 are declared sterile.
Devices declared under this manufacturer
- Babyhaler
- Biopsy Punch
- Relenza
- Stiefel Curette
- Volumatic Spacer Device
Catalogue references include 28003140, 28003170, 61569, 70592, 89753, 89754.
European nomenclature codes declared: A01020302, R03010380, A01020303, R03010302.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 12 |
| Country of registration | Ireland |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 12 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. GlaxoSmithKline Trading Services Limited was not found in either the U.S. or the Canadian register.